This study aims to investigate a drug called Cabozantinib which belongs to a family of drugs
that have effects on tumour growth, blood supply, invasion and spread.
Therefore, we want to find out whether taking cabozantinib after treatment with surgery and
chemotherapy is effective and safe for patients who responded or had stable disease after
their chemotherapy.
All participants will receive 4-6 cycles of standard chemotherapy. Those with stabilization
or response to the standard chemotherapy will be split into 2 groups (cabozantinib or
placebo).
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators:
Gynecologic Oncology Group NHS Greater Glasgow and Clyde